Company Filing History:
Years Active: 2018-2019
Title: Hermanus Meurs: Innovator in Chronic Obstructive Airway Disease Treatment
Introduction
Hermanus Meurs is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of medicine, particularly in the treatment of chronic obstructive airway diseases. With a total of 3 patents, his work focuses on innovative compounds that aim to improve the quality of life for patients suffering from conditions such as chronic obstructive pulmonary disease (COPD) and asthma.
Latest Patents
Hermanus Meurs' latest patents include the development of 6-hydroxy-2,5,7,8-tetramethylchroman-compounds. These compounds are specifically designed for the treatment of chronic obstructive airway diseases, including COPD, asthma, and bronchiectasis. The invention also encompasses drug delivery devices, such as nebulizers, that utilize these compounds for effective treatment. The compounds include (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone and N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide, or their pharmaceutically acceptable salts or bases.
Career Highlights
Hermanus Meurs is currently associated with Sulfateq B.V., where he continues to innovate in the field of respiratory health. His work has been instrumental in advancing therapeutic options for patients with chronic airway diseases.
Collaborations
Hermanus collaborates with esteemed colleagues, including Adrianus Cornelis Van Der Graaf and Martina Schmidt. Their combined expertise contributes to the development of effective treatments in respiratory medicine.
Conclusion
Hermanus Meurs stands out as a dedicated inventor whose work in chronic obstructive airway disease treatment is making a significant impact. His innovative compounds and commitment to improving patient care highlight the importance of research and development in the medical field.